Iconovo Ab Is A Swedish Contract Development And Manufacturing Organizationcdmobased In Lundthe Company Specializes In Inhalation Solutions For The Pharmaceutical Industryfocusing On Developing Dry Powder Inhalersdpisand Formulations For Conditions Such As Asthma And Chronic Obstructive Pulmonary Diseasecopd With A Team Of Around 20 Employeesmany Of Whom Hold Advanced Degreesiconovo Is Committed To Innovation In Inhalation Technology The Company Offers Four Patented Inhaler Platformsincluding Icoone Nasala Designed For Intranasal Delivery Of Glp 1 Analogues To Treat Obesityiconovo Provides End To End Development Serviceswhich Encompass Device Designdry Powder Formulationanalytical Testingand Regulatory Supportthis Integrated Approach Allows Them To Collaborate Effectively With Global Pharmaceutical Companieshelping To Accelerate The Time To Market For Both Generic And Novel Drugs Iconovo S Revenue Reached 28 11 Million Sek In 2023Reflecting Its Project Based Business Modelthe Company Is Led By Ceo Johan Wa Borg And Emphasizes User Friendly Inhaler Design And Formulation Flexibility To Meet Evolving Market Needs
